Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of General Virology

• Publication date

  1993-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/0022-1317-74-11-2385PMID 7504073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

  1993cited by this paper
• Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

  1993cited by this paper
• Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

  1992influential reference
• Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

  1992influential reference
• At least five related, but distinct, hepatitis C viral genotypes exist.

  1992cited by this paper
• Sequence analysis of the 5' noncoding region of hepatitis C virus.

  1992cited by this paper
• Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes.

  1992influential reference
• Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability.

  1992influential reference
• The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

  1992cited by this paper
• A new type of hepatitis C virus in patients in Thailand.

  1992cited by this paper
• Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

  1992cited by this paper
• HCV genotypes in chronic hepatitis C and response to interferon.

  1992cited by this paper
• Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region

  1992cited by this paper
• Severity of liver disease with different hepatitis C viral clones.

  1991cited by this paper
• Severity of liver disease with different hepatitis C viral clones

  1991cited by this paper
• Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.

  1991cited by this paper
• Hypervariable regions in the putative glycoprotein of hepatitis C virus.

  1991influential reference
• Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

  1991cited by this paper
• Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

  1990cited by this paper

• Discrepant Diagnostic Results of Nested Polymerase Chain Reaction-based Genotyping in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection

  2021influential citation
• A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing

  2019cites this paper
• Detection of Hepatitis Virus B And C in Archival Autopsy Specimens of Liver Cirrhosis

  2019cites this paper
• The acceptability of serum sample storage for hepatitis C viral load analysis in chronic hepatitis C patients

  2019cites this paper
• Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C

  2019cites this paper
• Association of hyperuricemia with disease severity in chronic hepatitis C patients

  2018cites this paper
• Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.

  2018cites this paper
• Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients

  2018cites this paper
• Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes

  2018cites this paper
• The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.

  2018cites this paper
• Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals

  2018cites this paper
• Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

  2018cites this paper
• Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

  2018cites this paper
• Association of serial serum major histocompatibility complex class I chain‐related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication

  2018cites this paper
• A real world cost effectiveness analysis of interferon‐based therapy for HCV naïve super‐responders

  2018cites this paper
• Profile of the VERSANT HCV genotype 2.0 assay

  2018cites this paper
• Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy

  2018cites this paper
• Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study.

  2017cites this paper
• Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C

  2017cites this paper
• The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon‐free direct antiviral agents

  2017cites this paper
• Disease severity and erythropoiesis in chronic hepatitis C

  2017cites this paper
• A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan

  2017cites this paper
• Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in chronic hepatitis C patients

  2017cites this paper
• Non‐response to daclatasvir and asunaprevir therapy in patients co‐infected with hepatitis C virus genotypes 1 and 2

  2017cites this paper
• Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

  2017cites this paper
• Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database

  2017cites this paper
• C型慢性肝疾患患者に於けるHCVのセログルーピングとCore region PCR-based genotypingの判定結果比較：判定不能例・乖離例の解析とキメラウイルスの同定

  2016cites this paper
• Long‐term efficacy of Peg‐Interferon/Ribavirin with and without Lamivudine therapy for HBeAg‐positive hepatitis B and C dual infection

  2016cites this paper
• Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C

  2016cites this paper
• Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment

  2016cites this paper
• Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy

  2016cites this paper
• The hepatitis C virus core gene yields restriction fragments of variable length and polymorphism

  2016cites this paper
• Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

  2016cites this paper
• Table 2 Comparison of HCV serogroups determined by ELISA-based serogrouping and genotypes determined by core region-multiplex PCR and phylogenetic analysis of 5’UTR-core and NS5B region sequences

  2016cites this paper
• Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

  2016cites this paper
• Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.

  2015cites this paper
• Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

  2015cites this paper
• PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

  2015cites this paper
• Chronic hepatitis C infection is associated with insulin resistance and lipid profiles

  2015cites this paper
• Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin

  2015cites this paper
• The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients

  2015cites this paper
• Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing.

  2014cites this paper
• High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.

  2014cites this paper
• Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.

  2014cites this paper
• Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection

  2014cites this paper
• Clinical utility of host genetic IL‐28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

  2013cites this paper
• The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study

  2013cites this paper
• Status and Future Requirements Molecular Typing of Enteroviruses: Current

  2013cites this paper
• Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy

  2013cites this paper
• HEPATITIS C VIRUS GENOTYPES IN IRAQ

  2013cites this paper
• Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.

  2013cites this paper
• DISTRIBUTION OF GENOTYPES OF B AND C HEPATITIS VIRUSES IN GUILAN PROVINCE

  2012cites this paper
• Electrochemical DNA Detection Using Supramolecular Interactions

  2012cites this paper
• The outcomes of glucose abnormalities in pre‐diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy

  2012cites this paper
• Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C

  2012cites this paper
• Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1.

  2012cites this paper
• Phylogenetic and Genotyping of Hepatitis C Virus in Egypt

  2012cites this paper
• Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

  2012cites this paper
• COMP ARISON OF 5' NONCODING REGION PRIMER SETS IN THE DETECTION OF HEPATITIS C VIRUS USING REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION

  2012cites this paper
• Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study

  2012cites this paper
• Good Safety Profile and Efficacy of Leucocyte Interferon-α in Combination with Oral Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C

  2012cites this paper
• Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2

  2012cites this paper
• Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan

  2011cites this paper
• Use of Illumina Deep Sequencing Technology To Differentiate Hepatitis C Virus Variants

  2011cites this paper
• The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.

  2011cites this paper
• Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

  2011cites this paper
• Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.

  2011cites this paper
• Pegylated interferon plus ribavirin therapy improves pancreatic β‐cell function in chronic hepatitis C patients

  2011cites this paper
• mixed cryoglobulinemia Low-grade malignant lymphoma, hepatitis C virus infection, and

  2011cites this paper
• Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection

  2011cites this paper
• Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection

  2011cites this paper
• Evidence for separation of HCV subtype 1a into two distinct clades

  2011cites this paper
• Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan Koji YokoyamaMasaharu TakahashiTsutomu NishizawaShigeo Nagashima • Suljid JirintaiShigeru YotsumotoHiroaki OkamotoMariko Y. Momoi

  2011cites this paper
• Prevalence of Amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors

  2011cites this paper
• Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C.

  2010cites this paper
• Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.

  2010cites this paper
• leukemia Hepatitis C virus infection in children treated for acute lymphoblastic

  2010cites this paper
• Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.

  2010cites this paper
• Phylogenetics of HCV: Recent advances

  2010cites this paper
• SUSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE OF DIFFERENT HCV GENOTYPES TO INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY

  2010cites this paper
• Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C

  2010cites this paper
• Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

  2010cites this paper
• HCV Antibody Response and Genotype Distribution in Different Areas and Races of China

  2009cites this paper
• Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

  2009cites this paper
• NO EVIDENCE FOR PATIENT‐TO‐PATIENT TRANSMISSION OF HEPATITIS C VIRUS DURING UPPER GASTROINTESTINAL ENDOSCOPY: MOLECULAR STUDIES ON THREE ACUTE HEPATITIS C PATIENTS

  2009cites this paper
• Nucleotide identity and variability among different Pakistani hepatitis C virus isolates

  2009cites this paper
• Molecular analysis of transmission of hepatitis C virus in a nurse who acquired acute hepatitis C after caring for a viremic patient with epistaxis

  2009cites this paper
• Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.

  2009cites this paper
• Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.

  2009cites this paper
• Hepatitis C Virus Infection And Metabolic Syndrome—A Community‐Based Study in an Endemic Area of Taiwan

  2009cites this paper
• Colorimetric microwell plate reverse-hybridization assay for detection and genotyping of hepatitis C virus.

  2009cites this paper
• Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

  2008cites this paper
• Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study.

  2008cites this paper
• Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.

  2008cites this paper
• Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection

  2008cites this paper
• Development and evaluation of a sensitive enzyme-linked oligonucleotide-sorbent assay for detection of polymerase chain reaction-amplified hepatitis C virus of genotypes 1-6.

  2008cites this paper
• Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.

  2008cites this paper
• Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV‐infected CD20‐positive B‐cell lymphoma undergoing rituximab combination chemotherapy

  2008cites this paper
• RETRACTION of: A survey of hepatitis B and C prevalence amongst the homeless community of Prague

  2008cites this paper
• Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population‐based nationwide study

  2008cites this paper